Alkermes PLC (NAS:ALKS)
$ 24.62 0.28 (1.15%) Market Cap: 4.17 Bil Enterprise Value: 3.74 Bil PE Ratio: 9.73 PB Ratio: 3.32 GF Score: 66/100

Alkermes Plc Virtual Investor Day Transcript

Mar 25, 2021 / 01:00PM GMT
Release Date Price: $18.41 (+1.93%)
Sandra Coombs
Alkermes plc - Co-Head of IR

Good morning. Welcome to the 2021 Alkermes Investor Day, and thank you for joining us. I'm Sandy Coombs, Vice President of Investor Relations. I hope you find today's presentations informative.

During today's presentations, we will be making forward-looking statements based on our current expectations relating to, among other things, the company's future financial and operating performance; the potential therapeutic and commercial value of nemvaleukin and our other product candidates; advancement of our research and development programs; and our Value Enhancement Plan and broader corporate strategy. These forward-looking statements are neither promises nor guarantees and are subject to a high degree of uncertainty and risk. Please see Slide 2 of the investor presentation accompanying this webcast and our most recent annual report filed with the SEC for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot